These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

564 related items for PubMed ID: 23334650

  • 1. Serum circulating microRNA profiling for identification of potential breast cancer biomarkers.
    Mar-Aguilar F, Mendoza-Ramírez JA, Malagón-Santiago I, Espino-Silva PK, Santuario-Facio SK, Ruiz-Flores P, Rodríguez-Padilla C, Reséndez-Pérez D.
    Dis Markers; 2013; 34(3):163-9. PubMed ID: 23334650
    [Abstract] [Full Text] [Related]

  • 2. Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection.
    Schrauder MG, Strick R, Schulz-Wendtland R, Strissel PL, Kahmann L, Loehberg CR, Lux MP, Jud SM, Hartmann A, Hein A, Bayer CM, Bani MR, Richter S, Adamietz BR, Wenkel E, Rauh C, Beckmann MW, Fasching PA.
    PLoS One; 2012; 7(1):e29770. PubMed ID: 22242178
    [Abstract] [Full Text] [Related]

  • 3. Plasma Circulating Mirnas Profiling for Identification of Potential Breast Cancer Early Detection Biomarkers.
    Jusoh AR, Mohan SV, Lu Ping T, Tengku Din TADAAB, Haron J, Romli RC, Jaafar H, Nafi SN, Tuan Salwani TI, Yahya MM.
    Asian Pac J Cancer Prev; 2021 May 01; 22(5):1375-1381. PubMed ID: 34048164
    [Abstract] [Full Text] [Related]

  • 4. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
    Zhang L, Xu Y, Jin X, Wang Z, Wu Y, Zhao D, Chen G, Li D, Wang X, Cao H, Xie Y, Liang Z.
    Breast Cancer Res Treat; 2015 Nov 01; 154(2):423-34. PubMed ID: 26476723
    [Abstract] [Full Text] [Related]

  • 5. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
    Kodahl AR, Lyng MB, Binder H, Cold S, Gravgaard K, Knoop AS, Ditzel HJ.
    Mol Oncol; 2014 Jul 01; 8(5):874-83. PubMed ID: 24694649
    [Abstract] [Full Text] [Related]

  • 6. Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women.
    Motawi TM, Sadik NA, Shaker OG, El Masry MR, Mohareb F.
    Gene; 2016 Sep 30; 590(2):210-9. PubMed ID: 26827795
    [Abstract] [Full Text] [Related]

  • 7. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM, Sima C, Ugolini D, Neri M, Allen KE, Weiss GJ.
    J Thorac Oncol; 2011 Mar 30; 6(3):482-8. PubMed ID: 21258252
    [Abstract] [Full Text] [Related]

  • 8. Identification of circulating microRNA signatures for breast cancer detection.
    Chan M, Liaw CS, Ji SM, Tan HH, Wong CY, Thike AA, Tan PH, Ho GH, Lee AS.
    Clin Cancer Res; 2013 Aug 15; 19(16):4477-87. PubMed ID: 23797906
    [Abstract] [Full Text] [Related]

  • 9. Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer.
    Si H, Sun X, Chen Y, Cao Y, Chen S, Wang H, Hu C.
    J Cancer Res Clin Oncol; 2013 Feb 15; 139(2):223-9. PubMed ID: 23052693
    [Abstract] [Full Text] [Related]

  • 10. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
    Li M, Zhou Y, Xia T, Zhou X, Huang Z, Zhang H, Zhu W, Ding Q, Wang S.
    Breast Cancer Res Treat; 2018 Jul 15; 170(2):257-270. PubMed ID: 29557526
    [Abstract] [Full Text] [Related]

  • 11. A Signature of Four Circulating microRNAs as Potential Biomarkers for Diagnosing Early-Stage Breast Cancer.
    Itani MM, Nassar FJ, Tfayli AH, Talhouk RS, Chamandi GK, Itani ARS, Makoukji J, Boustany RN, Hou L, Zgheib NK, Nasr RR.
    Int J Mol Sci; 2021 Jun 06; 22(11):. PubMed ID: 34204158
    [Abstract] [Full Text] [Related]

  • 12. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
    Zhang K, Wang YW, Wang YY, Song Y, Zhu J, Si PC, Ma R.
    Gene; 2017 Jul 01; 619():10-20. PubMed ID: 28359916
    [Abstract] [Full Text] [Related]

  • 13. Analysis of serum genome-wide microRNAs for breast cancer detection.
    Wu Q, Wang C, Lu Z, Guo L, Ge Q.
    Clin Chim Acta; 2012 Jul 11; 413(13-14):1058-65. PubMed ID: 22387599
    [Abstract] [Full Text] [Related]

  • 14. Identification and validation of miRNAs as endogenous controls for RQ-PCR in blood specimens for breast cancer studies.
    McDermott AM, Kerin MJ, Miller N.
    PLoS One; 2013 Jul 11; 8(12):e83718. PubMed ID: 24391813
    [Abstract] [Full Text] [Related]

  • 15. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L, Qi H, Teng J, Su B, Chen H, Wang C, Xia Q.
    Tumour Biol; 2016 Jun 11; 37(6):7777-84. PubMed ID: 26695145
    [Abstract] [Full Text] [Related]

  • 16. Potential value of circulatory microRNA10b gene expression and its target E-cadherin as a prognostic and metastatic prediction marker for breast cancer.
    Dwedar FI, Shams-Eldin RS, Nayer Mohamed S, Mohammed AF, Gomaa SH.
    J Clin Lab Anal; 2021 Aug 11; 35(8):e23887. PubMed ID: 34264524
    [Abstract] [Full Text] [Related]

  • 17. Exosomal miR-1246 and miR-155 as predictive and prognostic biomarkers for trastuzumab-based therapy resistance in HER2-positive breast cancer.
    Zhang Z, Zhang L, Yu G, Sun Z, Wang T, Tian X, Duan X, Zhang C.
    Cancer Chemother Pharmacol; 2020 Dec 11; 86(6):761-772. PubMed ID: 33068176
    [Abstract] [Full Text] [Related]

  • 18. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
    Regazzo G, Terrenato I, Spagnuolo M, Carosi M, Cognetti G, Cicchillitti L, Sperati F, Villani V, Carapella C, Piaggio G, Pelosi A, Rizzo MG.
    J Exp Clin Cancer Res; 2016 Jul 30; 35(1):124. PubMed ID: 27476114
    [Abstract] [Full Text] [Related]

  • 19. Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer.
    McAnena P, Tanriverdi K, Curran C, Gilligan K, Freedman JE, Brown JAL, Kerin MJ.
    BMC Cancer; 2019 May 10; 19(1):436. PubMed ID: 31077182
    [Abstract] [Full Text] [Related]

  • 20. Serum microRNA-155 as a potential biomarker to track disease in breast cancer.
    Sun Y, Wang M, Lin G, Sun S, Li X, Qi J, Li J.
    PLoS One; 2012 May 10; 7(10):e47003. PubMed ID: 23071695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.